Erlocip 100mg, containing Erlotinib, is a targeted therapy drug used in the treatment of specific types of cancers. It is part of a class of medications called tyrosine kinase inhibitors (TKIs), designed to block cancer growth by targeting the epidermal growth factor receptor (EGFR) pathway.

Uses of Erlocip 100mg

1. Non-Small Cell Lung Cancer (NSCLC):

   • For patients with advanced or metastatic NSCLC, particularly those with EGFR mutations.
   • Often prescribed when chemotherapy is not effective.

2. Pancreatic Cancer:

   • Used in combination with gemcitabine for advanced or metastatic pancreatic cancer.

How Erlocip 100mg Works

• Mechanism of Action:
  Erlotinib, the active ingredient, inhibits the EGFR tyrosine kinase, a key protein in cell signaling pathways. By blocking this receptor, Erlocip prevents the growth and spread of cancer cells.

Dosage and Administration

• Form: Oral tablet
• Regular Portion: One tablet day to day, no less than 1 hour prior or 2 hours after a dinner.
• Dosage may vary based on the cancer type, patient condition, and response to treatment.

Common Side Effects

• Skin rash or acne-like reactions
• Diarrhea
• Nausea and vomiting
• Fatigue
• Loss of appetite
• Dry skin

Serious Side Effects

• Severe lung problems (interstitial lung disease)
• Liver or kidney issues
• Eye irritation or damage

Precautions

• Not recommended during pregnancy or breastfeeding.
• Avoid smoking, as it reduces the drug's effectiveness.
• Regular monitoring of liver, kidney function, and lung health is essential.